Prescribing, Policies and Pathways
The last day of operation for Hertfordshire and West Essex ICB was 31 March 2026. The information on this website has not been updated since 31 March 2026. The legacy policies, prescribing recommendations and pathways can be accessed on this website. Find out more
or
| Medicine / Guideline | Indication | RAG rating | Document type | Place |
|---|---|---|---|---|
| Chronic Pelvic Pain Endometriosis | n/a | Clinical pathways | South and West Hertfordshire | |
| Combodart ((tamsulosin/ dutasteride) | Benign prostatic hyperplasia | Double Red | n/a | Hertfordshire and West Essex ICB |
| Contraception | Contraception | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dapoxetine | Premature ejaculation | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Dienogest | Endometriosis | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Dilatation & curettage for heavy menstrual bleeding | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Doxylamine with Pyridoxine (Xonvea®) | Nausea and Vomiting in pregnancy | Red | n/a | Hertfordshire and West Essex ICB |
| Elleste Duet | Hormone replacement therapy (HRT) | Green | n/a | Hertfordshire and West Essex ICB |
| Emergency Contraception Guideline | Emergency Contraception | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Endometriosis | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Estriol cream patient letter | Vaginal atrophy due to oestrogen deficiency | Green | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Evorel | Hormone replacement therapy (HRT) Patches are 2nd choice when tablets not suitable | Green | n/a | Hertfordshire and West Essex ICB |
| Evorel conti | Hormone replacement therapy (HRT) Patches are 2nd choice when tablets not suitable | Green | n/a | Hertfordshire and West Essex ICB |
| Female Sterilisation | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Female Sterilisation Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Femoston | Hormone replacement therapy (HRT) | Green | n/a | Hertfordshire and West Essex ICB |
| Femoston conti | Hormone replacement therapy (HRT) | Green | n/a | Hertfordshire and West Essex ICB |
| Fertility treatment and referral criteria for tertiary level assisted conception (IVF/IUI) Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Fertility treatment and referral criteria for tertiary level assisted conception (IVF/IUI) | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Heavy Menstrual Bleeding (HMB) - Primary Care | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| HRT Hormone Replacement Therapy Guidance | HRT | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Hysterectomy for heavy menstrual bleeding | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Hysterectomy in Gender Dysphoria | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Hysterectomy In Gender Dysphoria Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Hysterectomy Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Incidental Ovarian Cyst | n/a | Clinical pathways | South and West Hertfordshire | |
| Infertility | n/a | Clinical pathways | East and North Hertfordshire | |
| IVF drugs | Infertility | Red | n/a | Hertfordshire and West Essex ICB |
| Labiaplasty, Vaginoplasty & Hymenorrhaphy | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Linzagolix | Uterine Fibroids | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Linzagolix | Endometriosis | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Management of Unscheduled Bleeding on Hormone Replacement Therapy (HRT) | n/a | Clinical pathways | South and West Hertfordshire | |
| Mirena levonorgestrel-releasing intrauterine system (IUS) | Contraception | Green | Decision document | Hertfordshire and West Essex ICB |
| Pentosan polysulfate sodium | Bladder pain syndrome | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Post-Menopausal Bleeding Management | n/a | Clinical pathways | East and North Hertfordshire | |
| Postcoital Bleeding in Pre-Menopausal Women | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Relugolix-estradiol-norethisterone acetate (Ryeqo) | Uterine fibroids | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Relugolix-estradiol-norethisterone acetate (Ryeqo) | Endometriosis | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Reversal of Sterilisation | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Sayana Press | Contraception | Green | Decision document | Hertfordshire and West Essex ICB |
| Testosterone | Menopause | n/a | Patient information | Hertfordshire and West Essex ICB |
| Ulipristal | Uterine fibroids | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Urogynaecology - Female Incontinence and Prolapse | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Vasectomy | n/a | Clinical policy | Hertfordshire and West Essex ICB |